News 2026
02.03.2026
Hörtipp: Geschlechtersensible Infektiologie
Dr. Bianca Schneider, Leiterin der Forschungsgruppe "Wirtsdeterminanten bei Lungeninfektionen" am Forschungszentrum Borstel, Leibniz Lungenzentrum erklärt in der aktuellen Folge "Forschung aktuell" vom #Deutschlandfunk, warum Männer häufiger an #Tuberkulose erkranken als Frauen und wie man ihre Forschungsergebnisse nutzen kann, um die Therapie in Zukunft zu verbessern. Und das nicht nur bei der Tuberkulose, sondern auch bei anderen Erregern:
26.02.2026
Christoph Lange receives the DZIF Prize for Translational Infection Research 2025
Double reason to celebrate: Shortly after receiving the Oskar Medical Award, the internationally renowned tuberculosis expert has now also been honored with the DZIF Prize for Translational Infection Research 2025. At the annual conference of the German Center for Infection Research in Bonn, he was recognized for his outstanding contributions to the prevention, diagnosis, and treatment of tuberculosis, particularly drug-resistant tuberculosis.
04.02.2026
Congratulations! Prof. Christoph Lange awarded the 2025 Oskar Medical Prize
Prof. Christoph Lange, Medical Director of the Research Center Borstel, Leibniz Lung Center, has been awarded the 2025 Oskar Medical Prize by the Oskar-Helene-Heim Foundation. The prize, worth €50,000, is one of the most highly endowed medical prizes in Germany.
02.02.2026
Renewed certification for berufundfamilie audit
The FZB has received confirmation of its “audit berufundfamilie” certification from the board of trustees of berufundfamilie Service GmbH. This is the third time that the FZB has been awarded the certificate with distinction in special recognition of its long-standing, sustainable family- and life-phase-conscious personnel policy. The certificate is regarded as a seal of quality for a strategically designed work-life balance policy.
30.01.2026
Asthma Research: Borstel study selected as “Editors Pick” by Allergy
A study by the Research Center Borstel, Leibniz Lung Center (FZB) on the role of interleukin (IL 6) in severe asthma exacerbations following viral infections has been selected as recommended reading by the editors of the journal Allergy. The publication is highlighted in the current January The publication is highlighted in the current January issue and is thus receiving special attention in the professional community.